Rabinowits, G.; Homsi, J.; Nikanjam, M.; Gentry, R.; Strasswimmer, J.; Venna, S.; Migden, M.; Chandra, S.; Ruiz, E.; Zhang, H.; McGinniss, J.; Seluzhytsky, A.; Desai, J. Demographics, Prior Therapies, and Reasons for Cemiplimab Treatment: Prospective CemiplimAb-Rwlc Survivorship and Epidemiology (C.A.S.E.) Study in Patients With Advanced Cutaneous Squamous Cell Carcinoma. J of Skin 2020, 4, s125.